Literature DB >> 15858058

Activation of protease-activated receptor-1 triggers astrogliosis after brain injury.

Olivier Nicole1, Anna Goldshmidt, Cecily E Hamill, Scott D Sorensen, Aristide Sastre, Polina Lyuboslavsky, John R Hepler, Robert J McKeon, Stephen F Traynelis.   

Abstract

We have studied the involvement of the thrombin receptor [protease-activated receptor-1 (PAR-1)] in astrogliosis, because extravasation of PAR-1 activators, such as thrombin, into brain parenchyma can occur after blood-brain barrier breakdown in a number of CNS disorders. PAR1-/- animals show a reduced astrocytic response to cortical stab wound, suggesting that PAR-1 activation plays a key role in astrogliosis associated with glial scar formation after brain injury. This interpretation is supported by the finding that the selective activation of PAR-1 in vivo induces astrogliosis. The mechanisms by which PAR-1 stimulates glial proliferation appear to be related to the ability of PAR-1 receptor signaling to induce sustained extracellular receptor kinase (ERK) activation. In contrast to the transient activation of ERK by cytokines and growth factors, PAR-1 stimulation induces a sustained ERK activation through its coupling to multiple G-protein-linked signaling pathways, including Rho kinase. This sustained ERK activation appears to regulate astrocytic cyclin D1 levels and astrocyte proliferation in vitro and in vivo. We propose that this PAR-1-mediated mechanism underlying astrocyte proliferation will operate whenever there is sufficient injury-induced blood-brain barrier breakdown to allow extravasation of PAR-1 activators.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15858058      PMCID: PMC6725104          DOI: 10.1523/JNEUROSCI.5200-04.2005

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  67 in total

Review 1.  Targeting proteinase-activated receptors: therapeutic potential and challenges.

Authors:  Rithwik Ramachandran; Farshid Noorbakhsh; Kathryn Defea; Morley D Hollenberg
Journal:  Nat Rev Drug Discov       Date:  2012-01-03       Impact factor: 84.694

2.  Blood-brain barrier pathophysiology in traumatic brain injury.

Authors:  Adam Chodobski; Brian J Zink; Joanna Szmydynger-Chodobska
Journal:  Transl Stroke Res       Date:  2011-12       Impact factor: 6.829

3.  Kallikrein 6 is a novel molecular trigger of reactive astrogliosis.

Authors:  Isobel A Scarisbrick; Maja Radulovic; Joshua E Burda; Nadya Larson; Sachiko I Blaber; Caterina Giannini; Michael Blaber; Alexander G Vandell
Journal:  Biol Chem       Date:  2012-04       Impact factor: 3.915

4.  Involvement of CLEC16A in activation of astrocytes after LPS treated.

Authors:  Xinmin Wu; Jing Li; Chun Chen; Yaohua Yan; Shengyang Jiang; Xiaohong Wu; Bai Shao; Jin Xu; Lihua Kang; Yeqing Huang; Lin Zhu; Yuhong Ji; Yilu Gao
Journal:  Neurochem Res       Date:  2011-10-15       Impact factor: 3.996

Review 5.  Proteinases and signalling: pathophysiological and therapeutic implications via PARs and more.

Authors:  R Ramachandran; M D Hollenberg
Journal:  Br J Pharmacol       Date:  2007-12-03       Impact factor: 8.739

6.  Astrocytic control of synaptic NMDA receptors.

Authors:  C Justin Lee; Guido Mannaioni; Hongjie Yuan; Dong Ho Woo; Melissa B Gingrich; Stephen F Traynelis
Journal:  J Physiol       Date:  2007-04-05       Impact factor: 5.182

7.  Critical role for PAR1 in kallikrein 6-mediated oligodendrogliopathy.

Authors:  Joshua E Burda; Maja Radulovic; Hyesook Yoon; Isobel A Scarisbrick
Journal:  Glia       Date:  2013-07-08       Impact factor: 7.452

Review 8.  G Protein-Coupled Receptor and RhoA-Stimulated Transcriptional Responses: Links to Inflammation, Differentiation, and Cell Proliferation.

Authors:  Olivia M Yu; Joan Heller Brown
Journal:  Mol Pharmacol       Date:  2015-04-22       Impact factor: 4.436

9.  Phospholipase Cepsilon is a nexus for Rho and Rap-mediated G protein-coupled receptor-induced astrocyte proliferation.

Authors:  Simona Citro; Sundeep Malik; Emily A Oestreich; Julie Radeff-Huang; Grant G Kelley; Alan V Smrcka; Joan Heller Brown
Journal:  Proc Natl Acad Sci U S A       Date:  2007-09-18       Impact factor: 11.205

10.  Bridging the Divide between Neuroprosthetic Design, Tissue Engineering and Neurobiology.

Authors:  Jennie B Leach; Anil Kumar H Achyuta; Shashi K Murthy
Journal:  Front Neuroeng       Date:  2010-02-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.